‡a
Author's Trans-3,5,4´-trimethoxystilbene reduced gefitinib resistance in NSCLCs via suppressing MAPK/Akt/Bcl-2 pathway by upregulation of miR-345 and miR-498
‡a
trans354trimethoxystilbenereducedgefitinibresistanceinnsclcsviasuppressingmapkaktbcl2pathwaybyupregulationofmir345andmir498
‡A
Trans-3,5,4´-trimethoxystilbene reduced gefitinib resistance in NSCLCs via suppressing MAPK/Akt/Bcl-2 pathway by upregulation of miR-345 and miR-498
‡9
1